Can businesses succeed in a world of corruption (without paying bribes)?
Jan 12, 2016 11:31 am UTC| Law Business
Every global business has to be careful about running afoul of the Foreign Corrupt Practices Act (FCPA), the federal law that prohibits paying bribes to foreign officials to obtain or retain business. The Justice...
LED Stadium Screens Market Expected to Reach US$1.9 bn by 2022 : Transparency Market Research
Jan 12, 2016 11:30 am UTC| Business
Albany, NY, Jan. 12, 2016 (GLOBE NEWSWIRE) -- The growing demand for LED screens, perimeter LED displays digital score boards in sports arena and stadiums and increasing size of sports venues has led to increased demand...
Jan 12, 2016 11:30 am UTC| Business
PLANO, Texas, Jan. 12, 2016 (GLOBE NEWSWIRE) -- Denbury Resources Inc. (NYSE:DNR) (“Denbury” or the “Company”) today announced that it has amended the “Limitation on Liens” covenant in its previously announced Exchange...
Construction Equipment Rental Market Worth $84.60Bn By 2022: Grand View Research, Inc.
Jan 12, 2016 11:05 am UTC| Business
San Francisco, Jan. 12, 2016 (GLOBE NEWSWIRE) -- The construction equipment rental market is expected to reach USD 84.60 billion by 2022, according to a new study by Grand View Research, Inc. Availability of wider...
Jan 12, 2016 10:30 am UTC| Business
Albany, NY, Jan. 12, 2016 (GLOBE NEWSWIRE) -- According to this report, the global sludge dewatering equipment market was valued at US$3.05 billion in 2014 and is projected to reach US$4.83 billion by 2023, at a CAGR of...
TAS Commercial Concrete Announces a Contract Award of Approximately $10 Million
Jan 12, 2016 10:00 am UTC| Business
HOUSTON, Jan. 12, 2016 (GLOBE NEWSWIRE) -- TAS Commercial Concrete, a wholly owned subsidiary of Orion Marine Group, Inc. (NYSE:ORN) (the "Company") a leading construction company, today announced a contract award of...
Affimed to Present at Noble Financial Capital Markets' 12th Annual Investor Conference
Jan 12, 2016 10:00 am UTC| Business
HEIDELBERG, Germany, Jan. 12, 2016 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq:AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today announced...